Please cite this article in press as: Liu et al., An axial-to-axial chirality transfer strategy for atroposelective construction of C–N axial chirality, Chem
ll
Article
An axial-to-axial chirality
transfer strategy for atroposelective
construction of C–N axial chirality
Ze-Shui Liu,1,4 Pei-Pei Xie,2,4 Yu Hua,1 Chenggui Wu,1 Yuanyuan Ma,1 Jiangwei Chen,1
Hong-Gang Cheng,1 Xin Hong,2,3, and Qianghui Zhou
*
SUMMARY
The bigger picture
Axial chirality widely exists in
bioactive natural products,
pharmaceuticals, chiral materials,
and chiral ligands and catalysts in
asymmetric catalysis. As such, the
efficient, modular, and
C–N axially chiral skeletons are ubiquitous in bioactive natural
products, pharmaceuticals, and chiral ligands. However, their atro-
poselective synthesis remains a formidable challenge because of
their innate low configurational stability compared with that of
well-developed C–C atropisomers. Herein, we report a general
and efficient method for accessing C–N atropisomers through an
axial-to-axial chirality transfer strategy based on palladium/chiral
norbornene cooperative catalysis. The obtained C–N axial chirality
originates from the preformed transient C–C axial chirality with
high fidelity. A variety of C–N axially chiral phenanthridinones
are obtained in excellent enantioselectivities (44 examples, up
to >99% ee). This method can be applied for the construction of
two stereogenic axes via double atroposelective C–H arylation
or further transformation of the products via axial-to-axial
diastereoinduction. Additionally, the reaction mechanism and the
chirality transfer process are elucidated by density functional
theory calculations.
enantioselective assembly of
these scaffolds from readily
available starting materials
represents one of the most
challenging yet fascinating
directions in synthetic organic
chemistry. In sharp contrast to the
well-developed C–C axial
chirality, atroposelective
construction of C–N axial chirality
has been less investigated
because of the innate higher
degree of rotational freedom of
the latter. Herein, we report an
efficient atroposelective
INTRODUCTION
As we know, C–C atropisomers, e.g., axially chiral biaryls, are prevalent and privi-
leged frameworks, and their construction has been well developed in the past de-
cades.1–4 C–N atropisomers, the siblings of C–C atropisomers, are also commonly
found in bioactive natural products,5 medicinal chemistry,6 and recently in asym-
metric catalysis as chiral ligands7 (Figure 1A). However, compared with that of
well-developed C–C atropisomers, the construction of C–N atropisomers has
been less explored, which is probably due to the innate higher degree of rotational
freedom and lower rotation barrier around a C–N bond.3,8–10 In 2002, the Taguchi11
and Curran12 groups independently reported the first asymmetric syntheses of atro-
pisomeric anilides through a palladium (Pd)-catalyzed N-allylation reaction, albeit
with unsatisfied enantioselectivities. Since then, a number of catalytic asymmetric
approaches have been developed for accessing these synthetically challenging skel-
etons (Figure 1B). Excellent stereoselectivities were obtained by means of N–H func-
tionalization of anilides, including Pd-catalyzed N-arylation (Buchwald-Hartwig
amination),13,14 intramolecular Ullmann-type amination,15 phase-transfer-catalyzed
N-alkylation,16 and cinchona alkaloid-catalyzed N-allylation.17–19 Efficient ap-
proaches to directly constructing the atropisomeric C–N bond were also devel-
oped.20–23 Other effective means included assembling the C–N atropisomers via
de novo construction of the aromatic ring24–27 and desymmetrization of prochiral
anilides.28–31 Recently, enantioselective C–H bond functionalization has emerged
construction of C–N atropisomers
via palladium/chiral norbornene
cooperative catalysis. The key to
success is the unique axial-to-axial
chirality transfer process, which
has been scarcely reported. This
strategy is expected to inspire
future studies in asymmetric
synthesis and find applications in
broad research fields.
Chem 7, 1–16, July 8, 2021 ª 2021 Elsevier Inc.
1